State Farm Mutual Automobile Insurance’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,513
Closed -$97K 117
2018
Q3
$97K Buy
+4,513
New +$105K ﹤0.01% 111
2017
Q3
Sell
-250,000
Closed -$8.3M 114
2017
Q2
$8.3M Hold
250,000
0.01% 100
2017
Q1
$8.02M Hold
250,000
0.01% 91
2016
Q4
$9.06M Hold
250,000
0.01% 86
2016
Q3
$11.5M Hold
250,000
0.02% 85
2016
Q2
$12.6M Hold
250,000
0.02% 84
2016
Q1
$13.4M Hold
250,000
0.02% 84
2015
Q4
$16.4M Hold
250,000
0.03% 83
2015
Q3
$14.1M Hold
250,000
0.02% 83
2015
Q2
$14.8M Sell
250,000
-88,800
-26% -$5.48M 0.02% 83
2015
Q1
$21.1M Sell
338,800
-257,800
-43% -$15M 0.03% 82
2014
Q4
$34.3M Sell
596,600
-59,100
-9% -$3.29M 0.05% 80
2014
Q3
$35.2M Hold
655,700
0.05% 79
2014
Q2
$34.4M Hold
655,700
0.05% 79
2014
Q1
$34.6M Sell
655,700
-935,500
-59% -$43.2M 0.05% 80
2013
Q4
$63.8M Hold
1,591,200
0.1% 79
2013
Q3
$60.1M Hold
1,591,200
0.11% 80
2013
Q2
$62.4M Buy
+1,591,200
New +$62M 0.11% 78

Other funds holding TEVA

State Farm Mutual Automobile Insurance's TEVA Position: Q4 2018 in Review

State Farm Mutual Automobile Insurance sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 4,513 shares — an estimated $97K sold.

State Farm Mutual Automobile Insurance first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $63.8M in Q4 2013. 552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • State Farm Mutual Automobile Insurance reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • State Farm Mutual Automobile Insurance sold 4,513 Teva Pharmaceuticals shares in Q4 2018, an estimated $97K.
  • State Farm Mutual Automobile Insurance first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • State Farm Mutual Automobile Insurance's Teva Pharmaceuticals position peaked at $63.8M in Q4 2013.
  • 552 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on State Farm Mutual Automobile Insurance's 13F filing for Q4 2018, filed 14 Feb 2019.